💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

One dead from Nipah virus in India's Kerala; second death this year

Published 09/16/2024, 04:40 AM
Updated 09/16/2024, 04:46 AM
© Reuters. FILE PHOTO: A patient, who according to medics is suffering from Nipah infection, is shifted to an ICU of Nipah isolation ward in Kozhikode Medical College in Kozhikode district in the southern state of Kerala, India, July 20, 2024. REUTERS/CK Thanseer/Fi

By Jose Devasia

KOCHI, India (Reuters) - A 24-year-old student has died from the Nipah virus in the southern Indian state of Kerala, a local medical official said on Monday, and 151 people who came into contact with the victim are under observation to prevent the spread of the deadly virus.

This is the second death caused by Nipah in Kerala since July. Nipah is classified as a priority pathogen by the World Health Organization (WHO) because of its potential to trigger an epidemic. There is no vaccine to prevent infection and no treatment to cure it.

Parts of Kerala are among those most at risk globally for outbreaks of the virus, a Reuters investigation showed last year. Nipah, which comes from fruit bats and animals such as pigs, can cause a lethal, brain-swelling fever in humans.

The student starting showing fever symptoms on Sept. 4 and died five days later, said R. Renuka, a district medical officer in the town of Malappuram, located in northern Kerala.

The testing of a blood sample from the victim sent to the National Institute of Virology in Pune confirmed a Nipah infection on Sept. 9, Renuka said.

Five other people who have developed primary symptoms of a Nipah infection have had blood samples drawn and they were sent for tests, she said, without saying if they were primary contacts of the dead person.

Nearly 151 people are being monitored for any symptoms after they were found to be on the primary contact list of the victim, who had come from Bengaluru, she said.

© Reuters. FILE PHOTO: A patient, who according to medics is suffering from Nipah infection, is shifted to an ICU of Nipah isolation ward in Kozhikode Medical College in Kozhikode district in the southern state of Kerala, India, July 20, 2024. REUTERS/CK Thanseer/File Photo

This is the second death from a Nipah infection in Malappuram this year after a 14-year-old boy succumbed in July.

Nipah has been linked to the deaths of dozens of people in Kerala since its first appearance in the state in 2018.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.